Cargando…
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
Diabetic kidney disease is one of the most frequent complications in patients with diabetes and constitutes a major cause of end-stage kidney disease. The prevalence of diabetic kidney disease continues to increase as a result of the growing epidemic of diabetes and obesity. Therefore, there is moun...
Autores principales: | Donate-Correa, Javier, Sanchez-Niño, María Dolores, González-Luis, Ainhoa, Ferri, Carla, Martín-Olivera, Alberto, Martín-Núñez, Ernesto, Fernandez-Fernandez, Beatriz, Tagua, Víctor G, Mora-Fernández, Carmen, Ortiz, Alberto, Navarro-González, Juan F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664582/ https://www.ncbi.nlm.nih.gov/pubmed/36381364 http://dx.doi.org/10.1093/ckj/sfac143 |
Ejemplares similares
-
Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
por: Donate-Correa, Javier, et al.
Publicado: (2019) -
Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2023) -
Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
por: Donate-Correa, Javier, et al.
Publicado: (2023) -
Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022) -
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
por: Donate-Correa, Javier, et al.
Publicado: (2021)